BFLY

Butterfly Network, Inc. (BFLY) - Q2 2026 10-Q Summary

Business Context and Reporting Period

This summary covers the quarterly period ended June 30, 2026. Butterfly Network, Inc. is a digital health company providing portable, semiconductor-based ultrasound technology and cloud-connected software. The company operates in a single reportable segment, focusing on its core business (probes and software) and its "Embedded" program, which licenses its Ultrasound-on-Chip™ platform for co-development in non-competitive markets.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Total revenue increased 39.5% year-over-year (Q2) and 32.6% year-over-year (YTD). This was driven by a 149.8% surge in "Software and other services" revenue, largely due to Embedded partnerships (including Midjourney, Inc.). Product revenue declined slightly (5.4% Q2, 1.3% YTD) due to the non-recurrence of prior-year semiconductor chip sales, partially offset by higher probe volume.
• Margin Expansion: Gross margin improved significantly to 71.4% in Q2 2026 from 63.7% in Q2 2025, reflecting the higher mix of software revenue.
• Expense Trends: Operating expenses increased to $37.0 million in Q2 2026 from $31.0 million in Q2 2025. "Other" expenses rose 80.6% due to litigation costs and loss contingencies, though this was partially offset by insurance recoveries. R&D expenses increased 26.8% due to headcount and engineering costs.
• Liquidity: Cash and cash equivalents decreased by approximately $25.8 million over the six-month period, primarily due to operating cash burn and working capital changes (deferred revenue and prepaid expenses).

Guidance, Outlook, and Risks

• Outlook: Management expects existing cash and operating cash flows to fund operations for at least the next 12 months. The company anticipates a continued shift in revenue mix toward software and services as device adoption grows.
• Key Risks & Contingencies:
  • Litigation: The company is involved in multiple legal proceedings, including a class action lawsuit (Rose v. Butterfly Network) and stockholder derivative actions. As of June 30, 2026, the company has accrued a $10.0 million estimated liability for loss contingencies related to indemnification obligations, offset by a $10.0 million insurance recovery asset.
  • Customer Concentration: One customer accounted for more than 10% of total revenue for the three and six months ended June 30, 2026.
  • Regulatory & Competition: Risks include the ability to maintain regulatory authorization and competition from companies with greater financial resources.
• Unusual Items: The "Other" expense line includes significant litigation costs and loss contingencies not considered representative of ongoing operations. Additionally, all unexercised warrants expired on February 12, 2026.

Investor Verification Checklist

• Verify the sustainability of the "Embedded" partnership revenue (specifically the Midjourney, Inc. collaboration) driving the software revenue spike.
• Review the status of ongoing litigation and the adequacy of the $10.0 million insurance recovery asset against potential future liabilities.
• Assess the impact of the single customer concentration (>10% of revenue) on future revenue stability.
• Monitor the burn rate of cash ($30.2 million used in operations YTD) against the $124.7 million cash balance to confirm the 12-month runway.
• Confirm the trajectory of product revenue growth to ensure it offsets the decline in one-time semiconductor chip sales.